TACTILE SYSTEMS TECHNOLOGY INC
No SEC Form 4 filings for $TCMD in the last 30 days.
See all $TCMD insider activity →TACTILE SYSTEMS TECHNOLOGY INC (TCMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tcmd-20260810xex99d1.htm EX-99.1 Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results MINNEAPOLIS, MN, August 10th, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology com
Tactile Medical (Nasdaq: TCMD) announced the full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation system. The company says it keeps the same use for chronic neuromuscular and respiratory conditions such as cystic fibrosis and bronchiectasis across ages, while adding a lighter, more adjustable vest and a redesigned controller. It also includes built-in Wi‑Fi/Bluetooth for connected care and clinician/payer data.
BTIG Research has reiterated a "Buy" rating for Tactile Systems Technology (NASDAQ:TCMD) and maintained a $40 price target, suggesting a potential 61% upside. Other analysts also have a "Moderate Buy" consensus with an average target of $38.60. The company recently reported mixed quarterly results, missing EPS estimates but exceeding revenue expectations, with shares trading around $24.84.
Over the past 7 days, alphai's AI scored 1 news story mentioning TCMD (TACTILE SYSTEMS TECHNOLOGY INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent TCMD coverage spans financial news, earnings and market movers.
The 8-K provides fresh earnings datapoints plus a guidance update, with a clear near-term demand timing risk tied to AffloVest inventory digestion.
Product upgrade and commercial rollout ahead of winter respiratory season could support incremental demand and adoption of connected therapy.
BTIG Research maintains a bullish outlook on Tactile Systems Technology, with a 'Buy' rating and a $40 target price, suggesting a 61% upside from the current share price of approximately $24.84. The company's recent mixed quarterly results and analyst consensus support a positive but cautious outlook.
The consensus 'Moderate Buy' rating and positive institutional movements suggest potential upside, but recent earnings miss introduces caution. Technical levels and industry comparison are not available for detailed technical analysis.
The VP's sale of $148,260.15 worth of stock indicates a potential profit-taking move after a positive earnings report, which may not necessarily signal a decline in company fundamentals.
alphai scores every news story that mentions TCMD with an AI model for sentiment and relevance, and aggregates insider trades from TACTILE SYSTEMS TECHNOLOGY INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
TACTILE SYSTEMS TECHNOLOGY INC (TCMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tcmd-20260810xex99d1.htm EX-99.1 Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results MINNEAPOLIS, MN, August 10th, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology com
6 min readTactile Medical (Nasdaq: TCMD) announced the full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation system. The company says it keeps the same use for chronic neuromuscular and respiratory conditions such as cystic fibrosis and bronchiectasis across ages, while adding a lighter, more adjustable vest and a redesigned controller. It also includes built-in Wi‑Fi/Bluetooth for connected care and clinician/payer data.
4 min readBTIG Research has reiterated a "Buy" rating for Tactile Systems Technology (NASDAQ:TCMD) and maintained a $40 price target, suggesting a potential 61% upside. Other analysts also have a "Moderate Buy" consensus with an average target of $38.60. The company recently reported mixed quarterly results, missing EPS estimates but exceeding revenue expectations, with shares trading around $24.84.
2 min readTactile Systems Technology, Inc. (NASDAQ:TCMD) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $38.60. Despite missing EPS estimates, the company exceeded revenue expectations in its latest quarter. Insider selling was observed, but institutional ownership remains high, with several major funds increasing or establishing positions.
3 min readTactile Systems Technology (NASDAQ:TCMD) VP Kristie Burns sold 5,139 shares of company stock for $148,260.15 on January 2nd, reducing her stake by 6.63%. This transaction follows an earnings beat for the company, which reported EPS of $0.36 against an expected $0.16 and revenue of $85.76 million versus $79.31 million projected. Shares traded up 1.2% to $30.50, and institutional investors own 83.43% of the stock.
2 min readHere is how Tactile Systems Technology (TCMD) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
3 min readTCMD, SWDBY and NPSNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 19, 2025.
2 min readTactile Systems Technology (TCMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 min readHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 min readTactile Systems Technology Inc ( NASDAQ:TCMD ) reported upbeat third-quarter earnings and raised FY2025 sales guidance on Monday. Tactile Systems Tech reported quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 17 cents per share.
3 min read
